Clinical trial of rosuvastatin tablets in the treatment of acute myocardial infarction瑞舒伐他汀片盐酸替罗非班注射液急性心肌梗死安全性目的 观察瑞舒伐他汀片治疗急性心肌梗死的临床疗效和安全性.方法 将126例急性心肌梗死病患者随机分为对照组63例和试验组63例.对照组予以口服瑞舒伐他汀10 mg,qn;试验组予...
Treatment of acute coronary syndrome with GLP-1 The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 mole... TR Coolid...
position, prolonged morning stiffness, night pain, weight loss or changes to bowel or bladder function. Even though the possibility of serious pathology after the history/interview seemed remote, we would still be mindful to consider it throughout the physical examination and subsequent treatment. For...
Myocardial infarction: Its clinical manifestations and treatment with anticoagulants - American Heart JournalIn this elaborately documented monograph the reader can examine for himself the data and statistical analyses on which the conclusions presented are based. This book represents an important contribution...
so no customized treatment is prescribed for these patients. Indeed, it may cause the discontinuation of ischemic treatment inappropriately. As a result, recurrent angina occurs in these patients causing impaired life quality, rec...
(GRACE),2 there are several major limitations of these existing models. First, some classic scores2-4 were developed nearly 2 decades ago, and may not be suitable for current practice with advances in treatment and awareness o...
Thoracic Surgery Branch of Shanghai Medical Association, Thoracic Surgery Branch of Shanghai Medical Doctor Association, Professional Alliance for Promotion and Improvement of Clinical Ability of General Thoracic Surgery. Expert consensus on the treatment of early-stage multiple primary lung cancers. Chines...
Congestive heart failure (CHF) is associated with cognitive deficits, particularly of memory and attention. The present study aims to clarify whether clinical treatment can reverse the attentional deficits of patients with CHF. A convenience sample of 50
of the TF activator12. However, given the requirement to transport and centrifuge the specimen, the CCT turnaround time is often too long (~1hr) to be reliable for informing treatment decisions particularly in the context of rapidly changing coagulation conditions in critically ill or injured ...
Hydroxyurea for prevention and treatment of vasoocclusive events: Mechanism of action: Increases HbF levels, RBC water content, deformability of sickle cells Alters adhesion of RBCs to endothelium Reduces pain and other vasoocclusive complications Decreases hospitalization rates Improves survival ...